Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses
Fátima Lasala(Research Institute Hospital 12 de Octubre), Carmen Gil(Instituto de Salud Carlos III), Alfonso García‐Rubia(Centro de Investigaciones Biológicas Margarita Salas), Isabel García-Dorival(Instituto de Salud Carlos III), Covadonga Alonso(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Rafaël Delgado(University of Vassouras), Miguel Ángel Cuesta-Geijo(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria), Joanna Luczkowiak(Research Institute Hospital 12 de Octubre), Paula Bueno(Research Institute Hospital 12 de Octubre), Carlos Requeña(Centro de Investigaciones Biológicas Margarita Salas), Inmaculada Galindo(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria), Nuria Labiod(Instituto de Salud Carlos III), Nuria E. Campillo(Centro de Investigaciones Biológicas Margarita Salas)
Cited by 22
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
|Autophagy|2016|6k
ICTV Virus Taxonomy Profile: Asfarviridae
|Journal of General Virology|2018|492
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348